The Kislinger Laboratory is located at the Princess Margaret Cancer Research Tower of the Princess Margaret Cancer Centre, the largest oncology treatment and research facility in Canada. The major goal of our lab is to apply proteomics technologies to cancer and cardiovascular research. Our research interests include technology development, using the latest generation of mass spectrometry instrumentation, basic cell biology and translational cancer research.
Cancer Biol Ther. 2009 Feb;8(4):312-8
J Proteome Res. 2009 Mar;8(3):1610-6
Advances in ovarian cancer proteomics: the quest for biomarkers and improved therapeutic interventions.
Expert Rev Proteomics. 2008 Aug;5(4):551-60
Identification of pathways associated with invasive behavior by ovarian cancer cells using multidimensional protein identification technology (MudPIT).
Mol Biosyst. 2008 Jul;4(7):762-73
Proteomics Clin Appl. 2008 May;2(5):638-53
Clin Pharmacol Ther. 2008 May;83(5):758-60
The Glc7 phosphatase subunit of the cleavage and polyadenylation factor is essential for transcription termination on snoRNA genes.
Mol Cell. 2008 Mar 14;29(5):577-87
A proteome resource of ovarian cancer ascites: integrated proteomic and bioinformatic analyses to identify putative biomarkers.
J Proteome Res. 2008 Jan;7(1):339-51
Comparative proteomics profiling of a phospholamban mutant mouse model of dilated cardiomyopathy reveals progressive intracellular stress responses.
Mol Cell Proteomics. 2008 Mar;7(3):519-33
Cell. 2007 Nov 30;131(5):915-26
Senior Scientist, Princess Margaret Cancer Centre